Patents by Inventor Mark C. Armstrong

Mark C. Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240189304
    Abstract: Methods for the treatment of condition associated with bromodomain and extraterminal domain (BET) protein activity are disclosed. The methods include administering a therapeutically effective amount of a piperazine BET protein inhibitor or a piperidine BET protein inhibitor to a subject in need thereof. Piperazine BET protein inhibitors, piperidine BET protein inhibitors, and pharmaceutical compositions comprising the BET proteins inhibitors are also described.
    Type: Application
    Filed: March 2, 2022
    Publication date: June 13, 2024
    Applicants: The Regents of the University of California, Ohio State Innovation Foundation, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Allen C. Gao, Pui-Kai Li, Mark Foster, Ross Larue, Cameron M. Armstrong, Wei Lou, Shu Ning, Enming Xing
  • Patent number: D392984
    Type: Grant
    Filed: February 12, 1997
    Date of Patent: March 31, 1998
    Assignee: Sales & Marketing Services of Wisconsin
    Inventor: Mark C. Armstrong
  • Patent number: D395438
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: June 23, 1998
    Assignee: Sales & Marketing Services of Wi
    Inventor: Mark C. Armstrong
  • Patent number: D1003426
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: October 31, 2023
    Assignee: MONASH UNIVERSITY
    Inventors: Richard Morfuni, Daphne Flynn, Rowan Page, Mark C. Armstrong, Tuncay Alan, Jason Brenker
  • Patent number: D1019932
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: March 26, 2024
    Assignee: Monash University
    Inventors: Richard Morfuni, Daphne Flynn, Rowan Page, Mark C. Armstrong, Tuncay Alan, Jason Brenker